Dr Sarah Tedjasukmana
Clinical Articles iconClinical Articles

1 in 3 people with diabetic retinopathy are at high risk of vision loss, yet screening rates remain low…

Prof Sunil Badve
Videos iconVideos

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

Prof Duncan Topliss AM
Podcasts iconPodcasts

The questions answered in this podcast are listed below. They were compiled by GPs and health professionals around Australia.

Prof Ego Seeman
Videos iconVideos

In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Healthed Logo
Learning Modules iconLearning Modules

Pancreatic disease can have extensive consequences on a patient’s health and well-being. Pancreatic disease can often be silent, subtle and deceptive. Moreover, our understandings of how to tackle these diseases and their major consequences continues to evolve. This expert-led education module focuses on three of the commonest pancreatic disorders: cancer, chronic pancreatitis and pancreatic exocrine insufficiency. These presentations provide authoritative and practical explanations to help you develop your understanding of the diagnosis and management of these conditions.

A/Prof Kenneth Ho
Videos iconVideos

In this Product Explainer Endocrinologist A/Prof Kenneth Ho explains the role of testosterone scrotal cream for male hypogonadism confirmed by clinical assessment and measurement of serum testosterone (5 mins).

Dr David Yeo
Videos iconVideos

In this Product Explainer Hepatobiliary Surgeon Dr David Yeo explains the role of pancreatic enzyme supplements for pancreatic exocrine insufficiency, especially the importance of educating patients on correct dosing requirements to optimise nutrient absorption (7 mins).

Expert/s: Dr David Yeo
Fiona Clark
Clinical Articles iconClinical Articles

Pancreatic cancer is often diagnosed at late stage, leading to poor survival rates, but advances in molecular profiling and development of gene-targeted drugs could offer hope for the future

Expert/s: Fiona Clark
Prof John Zalcberg
Podcasts iconPodcasts

Pancreatic cancer accounts for about 3% of all newly diagnosed cancers and yet was the 3rd most common cause of cancer death last year

Prof Richard O'Brien
Videos iconVideos

In this Product Explainer, Endocrinologist Prof Richard O'Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).

Clinical Articles iconClinical Articles

Tune in to our special thyroid podcast series, hosted by Dr David Lim.

Expert/s: Healthed
Dr Agnieszka Lemanska
Clinical Articles iconClinical Articles

Every year, more than 10,000 people in the UK are diagnosed with pancreatic cancer. Unfortunately, for most of those people, the disease is diagnosed too late to be cured. Less than 10% of people live five years following a diagnosis.